These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 33441556)

  • 1. Establishing a clinical service to prevent psychosis: What, how and when? Systematic review.
    Salazar de Pablo G; Estradé A; Cutroni M; Andlauer O; Fusar-Poli P
    Transl Psychiatry; 2021 Jan; 11(1):43. PubMed ID: 33441556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outreach and support in South-London (OASIS) 2001-2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis.
    Fusar-Poli P; Spencer T; De Micheli A; Curzi V; Nandha S; McGuire P
    Eur Neuropsychopharmacol; 2020 Oct; 39():111-122. PubMed ID: 32921544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annual Research Review: Prevention of psychosis in adolescents - systematic review and meta-analysis of advances in detection, prognosis and intervention.
    Catalan A; Salazar de Pablo G; Vaquerizo Serrano J; Mosillo P; Baldwin H; Fernández-Rivas A; Moreno C; Arango C; Correll CU; Bonoldi I; Fusar-Poli P
    J Child Psychol Psychiatry; 2021 May; 62(5):657-673. PubMed ID: 32924144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention.
    Fusar-Poli P; Salazar de Pablo G; Correll CU; Meyer-Lindenberg A; Millan MJ; Borgwardt S; Galderisi S; Bechdolf A; Pfennig A; Kessing LV; van Amelsvoort T; Nieman DH; Domschke K; Krebs MO; Koutsouleris N; McGuire P; Do KQ; Arango C
    JAMA Psychiatry; 2020 Jul; 77(7):755-765. PubMed ID: 32159746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public health primary prevention implemented by clinical high-risk services for psychosis.
    Estradé A; Salazar de Pablo G; Zanotti A; Wood S; Fisher HL; Fusar-Poli P
    Transl Psychiatry; 2022 Jan; 12(1):43. PubMed ID: 35091529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the implementation and challenges of clinical services for psychosis prevention in England.
    Estradé A; Spencer TJ; De Micheli A; Murguia-Asensio S; Provenzani U; McGuire P; Fusar-Poli P
    Front Psychiatry; 2022; 13():945505. PubMed ID: 36660464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worldwide implementation of clinical services for the prevention of psychosis: The IEPA early intervention in mental health survey.
    Kotlicka-Antczak M; Podgórski M; Oliver D; Maric NP; Valmaggia L; Fusar-Poli P
    Early Interv Psychiatry; 2020 Dec; 14(6):741-750. PubMed ID: 32067369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based psychotherapy for the prevention and treatment of first-episode psychosis.
    Müller H; Laier S; Bechdolf A
    Eur Arch Psychiatry Clin Neurosci; 2014 Nov; 264 Suppl 1():S17-25. PubMed ID: 25261211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline Antipsychotic Dose and Transition to Psychosis in Individuals at Clinical High Risk: A Systematic Review and Meta-Analysis.
    Raballo A; Poletti M; Preti A
    JAMA Psychiatry; 2024 Jul; 81(7):727-730. PubMed ID: 38506802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-rank symptoms and premorbid adjustment in young individuals at increased risk of developing psychosis.
    Morcillo C; Stochl J; Russo DA; Zambrana A; Ratnayake N; Jones PB; Perez J
    Psychopathology; 2015; 48(2):120-6. PubMed ID: 25720419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pan-London Network for Psychosis-Prevention (PNP).
    Fusar-Poli P; Estradé A; Spencer TJ; Gupta S; Murguia-Asensio S; Eranti S; Wilding K; Andlauer O; Buhagiar J; Smith M; Fitzell S; Sear V; Ademan A; De Micheli A; McGuire P
    Front Psychiatry; 2019; 10():707. PubMed ID: 31681029
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis.
    Salazar de Pablo G; Soardo L; Cabras A; Pereira J; Kaur S; Besana F; Arienti V; Coronelli F; Shin JI; Solmi M; Petros N; Carvalho AF; McGuire P; Fusar-Poli P
    Epidemiol Psychiatr Sci; 2022 Jan; 31():e9. PubMed ID: 35042573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Specialised first-episode psychosis services: a systematic review of the literature].
    Skalli L; Nicole L
    Encephale; 2011 May; 37 Suppl 1():S66-76. PubMed ID: 21600336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ohio State University Early Psychosis Intervention Center (EPICENTER) step-based care programme for individuals at clinical high risk for psychosis: study protocol for an observational study.
    Breitborde NJK; Guirgis H; Stearns W; Carpenter KM; Lteif G; Pine JG; Storey N; Wastler H; Moe AM
    BMJ Open; 2020 Jan; 10(1):e034031. PubMed ID: 31992606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence that antipsychotic medication does not prevent long-term psychosis in higher-risk individuals.
    Zhang T; Wang J; Xu L; Wei Y; Tang X; Hu Y; Cui H; Tang Y; Li C; Ling Z; Wang J
    Eur Arch Psychiatry Clin Neurosci; 2022 Jun; 272(4):591-602. PubMed ID: 34536114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probability of Transition to Psychosis in Individuals at Clinical High Risk: An Updated Meta-analysis.
    Salazar de Pablo G; Radua J; Pereira J; Bonoldi I; Arienti V; Besana F; Soardo L; Cabras A; Fortea L; Catalan A; Vaquerizo-Serrano J; Coronelli F; Kaur S; Da Silva J; Shin JI; Solmi M; Brondino N; Politi P; McGuire P; Fusar-Poli P
    JAMA Psychiatry; 2021 Sep; 78(9):970-978. PubMed ID: 34259821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world effectiveness of antipsychotic treatment in psychosis prevention in a 3-year cohort of 517 individuals at clinical high risk from the SHARP (ShangHai At Risk for Psychosis).
    Zhang T; Xu L; Tang X; Wei Y; Hu Q; Hu Y; Cui H; Tang Y; Hui L; Li C; Cao L; Lu Z; Wang J
    Aust N Z J Psychiatry; 2020 Jul; 54(7):696-706. PubMed ID: 32436725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychoeducation for individuals at clinical high risk for psychosis: A scoping review.
    Herrera SN; Sarac C; Phili A; Gorman J; Martin L; Lyallpuri R; Dobbs MF; DeLuca JS; Mueser KT; Wyka KE; Yang LH; Landa Y; Corcoran CM
    Schizophr Res; 2023 Feb; 252():148-158. PubMed ID: 36652831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ITAlian partnership for psychosis prevention (ITAPP): Improving the mental health of young people.
    Fusar-Poli P; Minichino A; Brambilla P; Raballo A; Bertolino A; Borgatti R; Mensi M; Ferro A; Galderisi S
    Eur Psychiatry; 2021 Sep; 64(1):e62. PubMed ID: 34544509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.